Showing results (221-230 of 385) with videos related to

Sort By:
Pageof 39
BJU International|April 22, 2011
Comparison of risk calculators from the Prostate Cancer Prevention Trial and the European Randomized Study of Screening for Prostate Cancer in a contemporary Canadian cohortGreg Trottier, Monique J Roobol, Nathan Lawrentschuk, et al.
European Radiology|April 27, 2018
Magnetic resonance guided focused high frequency ultrasound ablation for focal therapy in prostate cancer - phase 1 trialSangeet Ghai, Nathan Perlis, Uri Lindner, et al.
JAMA Network Open|July 2, 2021
Association of Chemotherapy, Enzalutamide, Abiraterone, and Radium 223 With Cognitive Function in Older Men With Metastatic Castration-Resistant Prostate CancerShabbir M H Alibhai, Henriette Breunis, Gregory Feng, et al.
Plos One|March 14, 2009
Discovery of novel hypermethylated genes in prostate cancer using genomic CpG island microarraysKen Kron, Vaijayanti Pethe, Laurent Briollais, et al.
BJU International|December 9, 2016
Development and external validation of a biopsy-derived nomogram to predict risk of ipsilateral extraprostatic extensionRashid Sayyid, Nathan Perlis, Ardalanejaz Ahmad, et al.
The Journal of Urology|September 30, 2015
An Increase in Gleason 6 Tumor Volume While on Active Surveillance Portends a Greater Risk of Grade Reclassification with Further FollowupMaria Komisarenko, Lih-Ming Wong, Patrick O Richard, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|November 23, 2021
Trimodal therapy vs. radical cystectomy for muscle-invasive bladder cancer: A Markov microsimulation modelDiana Magee, Douglas Cheung, Amanda Hird, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|June 23, 2020
Optimizing screening and management of cardiovascular health in prostate cancer: A reviewMiran Kenk, Jean C Grégoire, Marc-Andre Coté, et al.
European Urology|September 22, 2009
The pathologist's mean grade is constant and individualizes the prognostic value of bladder cancer gradingBas W G van Rhijn, Geert J L H van Leenders, Bert C M Ooms, et al.
European Urology|January 8, 2011
Impact of 5α-reductase inhibitors on men followed by active surveillance for prostate cancerAntonio Finelli, Greg Trottier, Nathan Lawrentschuk, et al.
Pageof 39